Imaging of angiogenesis: from microscope to clinic (Q31144032)

29 June 2017

1 reference

title

Imaging of angiogenesis: from microscope to clinic (English)

1 reference

29 June 2017

1 reference

1 reference

Donald M McDonald

1 reference

29 June 2017

Peter L Choyke

series ordinal

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

29 June 2017

1 reference

29 June 2017

1 reference

29 June 2017

1 reference

29 June 2017

page(s)

713-725

1 reference

In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Scaling down imaging: molecular mapping of cancer in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Functional and molecular MR imaging of angiogenesis: seeing the target, seeing it work

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Molecular imaging of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Shedding light onto live molecular targets

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Universal GFP reporter for the study of vascular development.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Microvessel density in renal cell carcinoma: Lack of prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Openings between defective endothelial cells explain tumor vessel leakiness

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Imaging the microcirculation of untreated and treated human choroidal melanomas

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Therapeutic angiogenesis in critical limb and myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Quantified color Doppler sonography of tumor vascularity in an animal model

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Clinical applications of ultrasound contrast agents

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Ultrasound contrast agents: basic principles

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Dissecting tumour pathophysiology using intravital microscopy

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Role of nitric oxide in angiogenesis and microcirculation in tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

In vivo assessment of vascular endothelial growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

PET instrumentation: what are the limits?

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Vascular and interstitial barriers to delivery of therapeutic agents in tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Three-dimensional visualization and quantitation of fibrin in solid tumors by confocal laser scanning microscopy

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Perfusion of single tumor microvessels: application to vascular permeability measurement

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Challenges for imaging angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Application of CT in the investigation of angiogenesis in oncology

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Endothelial cells of tumor vessels: abnormal but not absent.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Expression of the 85-kd membrane protein in primary human breast cancer: relationship to hormone receptor levels, DNA ploidy, and tumor grade

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Probing the structural and molecular diversity of tumor vasculature

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Analysis of mural cell recruitment to tumor vessels

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Pericyte involvement in capillary sprouting during angiogenesis in situ

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Contractile proteins in pericytes. I. Immunoperoxidase localization of tropomyosin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Supramolecular assembly of basement membranes

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

BOLD MRI of human tumor oxygenation during carbogen breathing

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Prognostic radiology: quantitative assessment of tumor oxygen dynamics by MRI.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Regression of blood vessels in the ventral velum of Xenopus laevis Daudin during metamorphosis: light microscopic and transmission electron microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Assessment of antiangiogenic effect using 99mTc-EC-endostatin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Identification and functional assessment of endothelial P1H12.

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Lymphatic metastasis in the absence of functional intratumor lymphatics

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Lectins as markers of endothelial cells: comparative study between human and animal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FNM0603-713

7 January 2021

Identifiers

DOI

10.1038/NM0603-713

1 reference

Dimensions Publication ID

29 June 2017

1008659620

0 references

1 reference